Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Exploratory Phase 2a Study Evaluating the Efficacy and Safety of URO-902 in Subjects With Overactive Bladder and Urge Urinary Incontinence

NCT04211831 is registered in ClinicalTrials.gov with Urovant Sciences GmbH as lead sponsor.

NCT NCT04211831
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04211831 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Exploratory Phase 2a Study Evaluating the Efficacy and Safety of URO-902 in Subjects With Overactive Bladder and Urge Urinary Incontinence
Lead sponsor
Urovant Sciences GmbH
Phase
Phase 2
Overall status
Completed
Start date
December 16, 2019
Completion date
July 20, 2022
Enrollment
80 (actual)
Sites
20

Conditions

As the registry lists them; a condition with its own page is linked.

overactive bladder with urge urinary incontinence